Although high soy consumption may be associated with lower breast cancer risk in Asian populations, findings from epidemiological studies have been inconsistent.
We investigated the effects of soy intake on breast cancer risk among Korean women according to their menopausal and hormone receptor status.
We conducted a case–control study with 358 incident breast cancer patients and 360 age-matched controls with no history of malignant neoplasm. Dietary consumption of soy products was examined using a 103-item food frequency questionnaire.
The estimated mean intakes of total soy and isoflavones from this study population were 76.5 g per day and 15.0 mg per day, respectively. Using a multivariate logistic regression model, we found a significant inverse association between soy intake and breast cancer risk, with a dose–response relationship (odds ratios (OR) (95% confidence interval (CI)) for the highest vs the lowest intake quartile: 0.36 (0.20–0.64)). When the data were stratified by menopausal status, the protective effect was observed only among postmenopausal women (OR (95% CI) for the highest vs the lowest intake quartile: 0.08 (0.03–0.22)). The association between soy and breast cancer risk did not differ according to estrogen receptor (ER)/progesterone receptor (PR) status, but the estimated intake of soy isoflavones showed an inverse association only among postmenopausal women with ER+/PR+ tumors.
Our findings suggest that high consumption of soy might be related to lower risk of breast cancer and that the effect of soy intake could vary depending on several factors.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ahn SH (2004). Clinical characteristics of breast cancer patients in Korea in 2000. Arch Surg 139, 27–30; discussion 31.
Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG (2004). Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25, 1649–1657.
Allred CD, Twaddle NC, Allred KF, Goeppinger TS, Churchwell MI, Ju YH et al. (2005). Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice. J Agric Food Chem 53, 8542–8550.
Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J et al. (2001). Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85, 372–378.
Do MH, Lee SS, Jung PJ, Lee MH (2007). Intake of fruits, vegetables, and soy foods in relation to breast cancer risk in Korean women: a case-control study. Nutr Cancer 57, 20–27.
Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS (1999). Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 84, 3479–3484.
Fuhrman BJ, Teter BE, Barba M, Byrne C, Cavalleri A, Grant BJ et al. (2008). Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women. Cancer Epidemiol Biomarkers Prev 17, 33–42.
Helferich WG, Andrade JE, Hoagland MS (2008). Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 16, 219–226.
Hirose K, Imaeda N, Tokudome Y, Goto C, Wakai K, Matsuo K et al. (2005). Soybean products and reduction of breast cancer risk: a case-control study in Japan. Br J Cancer 93, 15–22.
Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroishi T et al. (1995). A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86, 146–154.
Hsieh CY, Santell RC, Haslam SZ, Helferich WG (1998). Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58, 3833–3838.
Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB et al. (2006). Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101, 246–253.
Imhof M, Molzer S (2008). Effects of soy isoflavones on 17beta-estradiol-induced proliferation of MCF-7 breast cancer cells. Toxicol In Vitro 22, 1452–1460.
Kao YC, Zhou C, Sherman M, Laughton CA, Chen S (1998). Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106, 85–92.
Kim HA, Jeong KS, Kim YK (2008). Soy extract is more potent than genistein on tumor growth inhibition. Anticancer Res 28, 2837–2841.
Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN et al. (2009). Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 18, 1050–1059.
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263.
Li CI, Daling JR, Malone KE (2003). Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21, 28–34.
Linseisen J, Piller R, Hermann S, Chang-Claude J (2004). Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 110, 284–290.
Makela S, Poutanen M, Kostian ML, Lehtimaki N, Strauss L, Santti R et al. (1998). Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med 217, 310–316.
McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG (2002). The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 132, 3036–3041.
Messina M, McCaskill-Stevens W, Lampe JW (2006a). Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98, 1275–1284.
Messina M, Nagata C, Wu AH (2006b). Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1–12.
Messina MJ, Wood CE (2008). Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 7, 17.
MIHWAF (2007). The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Seoul, Korea.
Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH et al. (2008). Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res 10, R20.
Omoni AO, Aluko RE (2005). Soybean foods and their benefits: potential mechanisms of action. Nutr Rev 63, 272–283.
Park MK, Song Y, Joung H, Li SJ, Paik HY (2007). Establishment of an isoflavone database for usual Korean foods and evaluation of isoflavone intake among Korean children. Asia Pac J Clin Nutr 16, 129–139.
Pisani P, Bray F, Parkin DM (2002). Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97, 72–81.
Setchell KD, Brown NM, Lydeking-Olsen E (2002). The clinical importance of the metabolite equol—a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577–3584.
Surh J, Kim MJ, Koh E, Kim YK, Kwon H (2006). Estimated intakes of isoflavones and coumestrol in Korean population. Int J Food Sci Nutr 57, 325–344.
Suzuki T, Matsuo K, Tsunoda N, Hirose K, Hiraki A, Kawase T et al. (2008). Effect of soybean on breast cancer according to receptor status: a case-control study in Japan. Int J Cancer 123, 1674–1680.
Trock BJ, Hilakivi-Clarke L, Clarke R (2006). Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459–471.
Willett W (1998). Nutritional Epidemiology, 2nd edn. Oxford University Press: New York, NY.
Wu AH, Koh WP, Wang R, Lee HP, Yu MC (2008a). Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer 99, 196–200.
Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC (2002). Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491–1496.
Wu AH, Yu MC, Tseng CC, Pike MC (2008b). Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98, 9–14.
Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN et al. (1996). Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5, 901–906.
Xu X, Duncan AM, Wangen KE, Kurzer MS (2000). Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 9, 781–786.
Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S (2003). Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95, 906–913.
Zhang M, Yang H, Holman CD (2009). Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status. Breast Cancer Res Treat 118, 553–563.
This study was funded by the Korean Science and Engineering Foundation (R01-2007-000-11293-0).
The authors declare no conflict of interest.
About this article
Cite this article
Cho, Y., Kim, J., Park, KS. et al. Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status. Eur J Clin Nutr 64, 924–932 (2010). https://doi.org/10.1038/ejcn.2010.95
- hormone receptor
- breast cancer
Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer
Breast Cancer Research and Treatment (2020)
European Journal of Clinical Nutrition (2018)
DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk
Scientific Reports (2017)
Scientific Reports (2016)